Mass Spectrometry-based Proteomics in Microvascular Inflammation Diagnosis in Kidney Transplantation.

NACompletedINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

November 8, 2021

Primary Completion Date

May 5, 2024

Study Completion Date

May 5, 2024

Conditions
Kidney TransplantationGraft RejectionHumoral ImmunityProteomics
Interventions
DIAGNOSTIC_TEST

Mass spectrometry-based proteomics of FFPE biopsies and urine samples

"The biopsy and urine samples will be processed by the OncoProt platform (University of Bordeaux) for proteomic analysis by tandem mass spectrometry (label-free quantification) as follows:~* Biopsies: laser microdissection of the renal cortex, fixation reversion, protein extraction and electrophoretic migration, tryptic digestion.~* Urines: samples concentration by centrifugation/filtration and tryptic digestion according to a protocol adapted from the FASP method (Filter-Aided Sample Preparation)"

Trial Locations (3)

33000

Hôpital Pellegrin, Bordeaux

69003

Hôpital Edouard Herriot, Lyon

75015

Hôpital Necker, Paris

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT04851145 - Mass Spectrometry-based Proteomics in Microvascular Inflammation Diagnosis in Kidney Transplantation. | Biotech Hunter | Biotech Hunter